Načítá se...
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas
BACKGROUND: Programmed cell death ligand-1 (PD-L1) expression has been reported in up to 61% of high grade gliomas (HGG). The purpose of this study was to describe safety and efficacy of PD-1 inhibition in patients with refractory HGGs. METHODS: This Institutional Review Board approved single center...
Uloženo v:
| Vydáno v: | J Immunother Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735528/ https://ncbi.nlm.nih.gov/pubmed/29254497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0302-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|